Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti–PD-1 Therapies in Metastatic MelanomaDouglas B. Johnson, Naveen Dakappagari, Christine Vaupel et al.|Clinical Cancer Research|2018Cited by 176
Quantitative spatial profiling of PD-1/PD-L1 interaction and HLA-DR/IDO1 to predict outcomes to anti-PD-1 in metastatic melanoma (MM).Douglas B. Johnson, Jennifer Bordeaux, Ju‐Young Kim et al.|Journal of Clinical Oncology|2017Cited by 2